Bristol Myers Squibb (NYSE:BMY) and Bain Capital have announced the establishment of a new independent biopharmaceutical ...

We recently compiled a list of 11 Best Undervalued Stocks to Invest in Now. Lincoln National Corporation stands third on our ...

HS Hyosung Advanced Materials has selected Bain Capital as the preferred bidder for its tire steel cord business unit. According to the investment banking (IB) industry on the 28th, HS Hyosung ...

Bain Capital’s exit leaves Perpetual negotiating with Oaktree-backed financial planner roll-up AZ Next Generation Advisory.

Bain Capital's Bridge Data Centres (Bridge DC) has broken ground on a facility in Thailand. Located south of Bangkok in the ...

Large private investment firm, Bain Capital, plans to sell its majority stake in an insurance broker and agency network based ...

Bain Capital is on the cusp of signing a deal to buy UK broker Jensten from private equity (PE) firm Livingbridge, Insurance ...

Bain Capital has won big at Virgin by solving incredibly complex problems. CEO Mike Murphy will keep looking for trouble as he hunts in three key sectors.

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

(Reuters) -Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing immunology drugs, backed by Bain's $300 million financing round, ...

Princeton: Bristol Myers Squibb and Bain Capital have announced the formation of a new independent biopharmaceutical company, ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...